结果解读
| 评分 | 卒中严重程度 |
|---|---|
| 0 | 无卒中症状 |
| 1-4 | 轻度 |
| 5-15 | 中度 |
| 16-20 | 中~重度 |
| 21-42 | 重度 |
NIHSS用于评估卒中引起的功能损害程度，一共由11项测试组成，评分范围0~42。评分越高提示卒中越严重，并与卒中引起的脑损害的体积成正相关。
NIHSS在临床上主要用于：
1、基线评估：卒中后即刻评估严重程度；
2、评价治疗效果：治疗后定期进行重新评估；
3、评估患者预后：基线评估>16分的患者很有可能死亡；而基线评估<6分的患者则很有可能恢复良好；每增加1分，患者有良好转归的可能性就降低17%。
NIHSS中语言功能所占比例很高（7分），提示其对左脑损害的评估价值更高（98%的语言处理在左脑进行）。
参考文献
1. National Institute of Health, National Institute of Neurological Disorders and Stroke. Stroke Scale.http://www.ninds.nih.gov/doctors/NIH_Stroke_Scale.pdf.
2. NIH Stroke Scale Training,Part 2. Basic Instruction. Department of Health and Human Services, National Institute of Neurological Disorders and Stroke. The National Institute of Neurological Disorders and Stroke (NINDS) Version 2.0
3. Ver Hage ,. The NIH stroke scale: a window into neurological status. Nurse.Com Nursing Spectrum (Greater Chicago) [serial online]. September 12, 2011;24(15):44-49.
4. Singer O, Humpich M, Laufs H, Lanfermann H, Steinmetz H, Neumann-Haefelin T. Conjugate eye deviation in acute stroke: incidence, hemispheric asymmetry, and lesion pattern. Stroke; A Journal Of Cerebral Circulation [serial online]. November 2006;37(11):2726-2732. Available from: MEDLINE with Full Text, Ipswich, MA.
5. Schimmel M, Leemann B, Christou P, Kiliaridis S, Herrmann F, Muller F. Quantitative assessment of facial muscle impairment in patients with hemispheric stroke. Journal Of Oral Rehabilitation [serial online]. n.d.;NOV, 2011, 38.11, p800-p809, 10p.
6. Okuda B, Kawabata K, Tachibana H, Sugita M. Cerebral blood flow in pure dysarthria: role of frontal cortical hypoperfusion. Stroke; A Journal Of Cerebral Circulation [serial online]. January 1999;30(1):109-113. Available from: MEDLINE, Ipswich, MA.
7. Brott T, Adams HP, Olinger CP, et al: Measurements of acute cerebral infarction-a clinical examination scale. Stroke 1989;20:864-70
8. Goldstein LB, Bartels C, Davis JN. Interrater reliability of the NIH Stroke Scale. Arch Neurol. 1989;46:660-662.
9. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S, for the ATLANTIS Study Investigators. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS study: a randomized con- trolled trial. JAMA. 1999;282:2019-2026.
10. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke. 1998;29:4-11.
11. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F, for the PROACT investigators. Intra-arterial prourokinase for ischemic stroke: the PROACT II study: a randomized controlled trial. JAMA. 1999;282: 2003-2011.
12. Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, Starkman S, Grotta J, Spilker J, Khoury J, Brott T. Combined intra- venous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke. Emergency Management of Stroke (EMS) Bridging Trial. Stroke. 1999;30:2598-2605.
13. Eissa A, Krass I, Bajorek B. Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA). Journal Of Clinical Pharmacy & Therapeutics [serial online]. December 2012;37(6):620-629. Available from: CINAHL, Ipswich, MA. Accessed November 27, 2012.
14. Fink JN, Selim MH, Kumar S, et al: Is the association of National Institutes of Health Stroke Scale scores and acute magnetic resonance imaging stroke volume equal for pa- tients with right- and left-hemisphere ischemic stroke? Stroke 2002;33:954-8
15. Lyden P, Lu M, Jackson C, Marler J Kothari R, Brott T, Zivin J, for the NINDS tPA Stroke Trial Investigators. Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. Stroke. 1999;30:2347-2354.
16. Muir KW, Weir CJ, Murray GD, Povey C, Lees KR. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke. 1996;27:1817-1820.
17. Frankel MR, Morgenstern LB, Kwiatkowski T, Lu M, Tilley BC, Broderick JP, Libman R, Levine SR, Brott T, for the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial. Neu- rology. 2000;55:952-959.
18. Dehaan R, Horn J, Limburg M, et al: A comparison of 5 stroke scales with measures of disability, handicap, and quality-of-life. Stroke 1993;24:1178-81
19. Weimar C, Konig I, Kraywinkel K, Ziegler A, Diener H. Age and national institutes of health stroke scale score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia - Development and external validation of prognostic models. Stroke [serial online]. n.d.;35(1):158-162. Available from: Science Citation Index, Ipswich, MA. Accessed November 19, 2012.
20. Glymour M, Berkman L, Ertel K, Fay M, Glass T, Furie K. Lesion characteristics, NIH Stroke Scale, and functional recovery after stroke. American Journal Of Physical Medicine & Rehabilitation [serial online]. September 2007;86(9):725-733. Available from: CINAHL, Ipswich, MA. Accessed November 27, 2012.
21. Woo D, Broderick JP, Kothari RU, Lu M, Brott T, Lyden PD, Marler JR, Grotta JC, for the NINDS t-PA Stroke Study Group. Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? Stroke. 1999;30:2355-2359.
22. Adams H, Davis P, Hansen M, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke - A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology [serial online]. n.d.;53(1):126-131. Available from: Science Citation Index, Ipswich, MA.